Estudio descriptivo sobre el perfil de los pacientes derivados a la Unidad de Tratamiento del Dolor Crónico del Hospital Universitario de Gran Canaria Dr. Negrín (utdc-hugcdn) como base para la reorganización de esta / Descriptive study on the profile of patients sent to the Chronic Pain Treatment Unit of the University Hospital of Gran Canaria Dr. Negrín (utdc-hugcdn) as a basis for the reorganization of this

Objetivo: Conocer las necesidades y fortalezas de nuestra Unidad derivadas del conocimiento del perfil de paciente que es remitido para la atención en la misma. Pacientes y métodos: Estudio descriptivo transversal sobre 5000 pacientes derivados a nuestra Unidad entre 2017 y 2020. Se recogieron de forma anónima los siguientes datos: número de pacientes remitidos por mes, edad, sexo, servicio remisor, localización del dolor, pacientes/interconsultas preferentes, rechazados y atendidos previamente. De los 1000 primeros pacientes también se registraron los antecedentes quirúrgicos, existencia o no de obesidad y consumo de fármacos psicoactivos. Resultados: Son derivados para valoración unos 1560 pacientes de media anuales (130 al mes), con una edad media de 59,8 años (± 14,3) de los cuales el 62,6 % son mujeres. Un 62,08 % se encontraba en edad laboral. Los servicios asistenciales que remitieron más pacientes fueron: Traumatología, Neurocirugía, Unidad de Raquis y Rehabilitación. El 6,6 % de las derivaciones fueron calificadas como preferentes. Fueron rechazadas el 9,98 % de las interconsultas. Los tipos de dolores según su localización más frecuentes fueron: lumbalgia, cervicalgia y dolores generalizados. Se constató la toma habitual de ansiolíticos y/o antidepresivos en un 34,9 %, el 10,8 % eran obesos y el 10,3 % sufrían dolor crónico postquirúrgico. Conclusiones: El perfil del paciente predominante derivado a nuestra unidad suele ser el de un adulto mayor, en edad laboral, de género femenino, derivado desde el servicio de Traumatología y con dolor en la región lumbar, perfil muy similar al descrito en otras unidades del dolor del mundo occidental desarrollado. Más de 1 de cada 3 pacientes puede sufrir ansiedad y/o depresión, siendo también muy frecuente el dolor postquirúrgico y la obesidad.(AU)

Objective: Determine the shortcomings and strengths of our pain clinic derived from the knowledge of the profile of the patients who are referred for care in the clinic. Patients and methods: Cross-sectional descriptive study on 5000 patients referred to our pain clinic between 2017 y 2020. The following data were collected: number of patients referred per month, age, sex, referring service, location of pain, patients referred preferentially, rejected patients, and previously attended consultations. Data on surgical history, obesity, and use of psychoactive drugs were also recorded for the first 1000 patients. Results: An average of 1560 patients were referred for evaluation per year (130 per month), with a mean age of 59.8 years (± 14.3) of which 62.6 % are women and 62.08 % were of working age. The healthcare services that referred the most patients were Orthopedic Surgery, Neurosurgery, Spine Unit and Rehabilitation. 6.6 % of the requests were derived preferentially. Of the referrals, 9.98 % were rejected. The most frequent pain locations were low back pain, neck pain and generalized pain. In the The usual taking of anxiolytics and / or antidepressants was found in 34.9 %, 10.8 % were diagnosed as obese and 10.3 % were referred for chronic postoperative pain. Conclusions: The profile of the predominant patient referred to our pain clinic is an older adult, of working age, female, referred from the orthopedics department and with pain in the lumbar region. This described profile is very similar to other pain units in the developed western world. Almost one in 3 patients may suffer from anxiety and / or depression, and post-surgical pain and obesity are also very common.(AU)

Projeto ARTICULADOR: protocolo de atendimento psicoeducativo em manejo de dor baseado em hipnose ericksoniana e visualização guiada / ARTICULATOR Project: protocol of psychoeducational care in pain management based on ericksonian hypnosis and visualization guided

Introdução: A dor é uma experiência essencialmente subjetiva e multifatorial cujo manejo e o tratamento devem considerar os aspectos afetivos, sensoriais, autonômicos e comportamentais associados. Nessa perspectiva, a Área de Controle e Tratamento da Dor (ARDOR) do Instituto Nacional de Traumatologia e Ortopedia Jamil Andrade (INTO) identificou a necessidade de atualizar seu modus operandi mediante ao esgotamento do modelo assistencial vigente frente aos desafios da contemporaneidade. No rastro dessa mudança, os psicólogos atuantes na ARDOR são convidados a reinventar seu próprio modo de intervenção, articulando novas técnicas, processos e ações. Objetivos: O objetivo desta pesquisa é propor um novo protocolo assistencial em Saúde Mental na Clínica da Dor baseado na hipnose ericksoniana e na visualização guiada, associadas a práticas grupais e ações estratégicas de gerenciamento. O novo protocolo de atendimento está centrado em grupos psicoeducativos fechados, focais e breves, orientados para o manejo e enfrentamento da dor. Método: Buscou-se averiguar as evidências de eficácia da hipnose quanto ao manejo de dor através da elaboração de uma revisão sistemática da literatura e análise dos resultados obtidos de um estudo piloto com pacientes da clínica da dor. Ambos os estudos ­ teórico e prático ­ corroboraram para a elaboração do protocolo. Resultados: As evidências obtidas tanto na revisão sistemática quanto análise dos resultados do ensaio piloto apontaram a hipnose como sendo eficaz em pelo menos um aspecto no manejo da dor (redução da interferência, qualidade ou intensidade da dor). A catastrofização mostrou-se uma variável interveniente com um expressivo viés em alguns resultados, por isso foi incluída no protocolo. Conclusão: Enquanto práticas integrativas, a hipnose e a visualização guiada são técnicas eficazes no manejo da dor, sendo de fácil aplicação, podendo ser aprendida e transmitida adiante pelos pacientes. Este protocolo é passível de ser reproduzido em outras instituições. Recomenda-se que seja utilizado por profissional de saúde treinado e com experiência no trabalho com práticas integrativas

Introduction: Pain is an essentially subjective and multifactorial experience whose management and treatment must consider the associated affective, sensory, autonomic and behavioral aspects. In this perspective, the Pain Control and Treatment Area (ARDOR) of National Institute of Traumatology and Orthopedics Jamil Andrade (INTO) identified the need to update its modus operandi by exhausting the current care model in the face of contemporary challenges. In the wake of this change, the psychologists working at ARDOR are invited to reinvent their own way of intervention, articulating new techniques, processes and actions. Objectives: The objective of this research is to propose a new mental health care protocol at Clínica da Dor based on Ericksonian hypnosis and guided visualization, associated with group practices and strategic management actions. The new care protocol is centered on closed, focal and brief psychoeducational groups, oriented to the management and coping of pain. Method: We sought to investigate the evidence of the effectiveness of hypnosis in pain management through the development of a systematic review of the literature and analysis of the results obtained from a pilot study with patients in the pain clinic. Both studies - theoretical and practical - supported the preparation of the protocol. Results: The evidence obtained both in the systematic review and analysis of the results of the pilot project pointed out hypnosis as being effective in at least one aspect in pain management (reduction of interference, quality or intensity of pain). Catastrophization proved to be an intervening variable with a significant bias in some results, so it was included in the protocol. Conclusion: As an integrative practice, hypnosis and guided visualization are effective techniques for pain management, being easy to apply and can be learned and transmitted by patients. This protocol is capable of being reproduced in other institutions. it is recommended to be used by a trained health professional with experience working with integrative practices

Thirty-five Years of Acute Pain Services: Where Do We Go From Here?

Acute pain services (APS) have developed over the past 35 years. Originally implemented solely to care for patients with regional catheters or patient-controlled analgesia after surgery, APS have become providers of care throughout the perioperative period, with some institutions even taking the additional step toward providing outpatient services for patients with acute pain. Models vary considerably in terms of tasks and responsibilities, staffing, education, protocols, quality, and financing. Many challenges face today's APS, including the increasing number of patients with preexisting chronic pain, intake of analgesics and opioids before surgery, substance-dependent patients needing special care, shorter hospital stays, early discharge of patients in need of further analgesic treatment, prevention and treatment of chronic postsurgical pain, minimization of adverse events, and side effects of treatment. However, many APS lack a clear-cut definition of their structures, tasks, and quality. Development of APS in the future will require us to face urgent questions, such as, "What are meaningful outcome variables?" and, "How do we define high quality?" It is obvious that focusing exclusively on pain scores does not reflect the complexity of pain and recovery. A broader approach is needed-a common concept of surgical and anesthesiological services within a hospital (eg, procedure-specific patient pathways as indicated by the programs "enhanced recovery after surgery" or the "perioperative surgical home"), with patient-reported outcome measures as one central quality criterion. Pain-related functional impairment, treatment-induced side effects, speed of mobilization, as well as return to normal function and everyday activities are key.

Association of trainee involvement in an acute pain service with postoperative opioid use in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

BACKGROUND: Several hospitals have implemented a multidisciplinary Acute Pain Service (APS) to execute surgery-specific opioid sparing analgesic pathways. Implementation of an anesthesia attending-only APS has been associated with decreased postoperative opioid consumption, time to ambulation, and time to solid food intake for patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. In this study, we evaluated the impact of introducing an APS trainee on postoperative opioid consumption in patients undergoing hyperthermic intraperitoneal chemotherapy during POD 0-3. METHODS: We performed a retrospective propensity-matched cohort study where we compared opioid consumption and hospital length of stay among two historical cohorts: attending-only APS service versus service involving a regional anesthesia fellow. RESULTS: In the matched cohorts, the median postoperative day (POD) 0-3 opioid use [25%, 75% quartile] for the single attending and trainee involvement cohort were 38.5 mg morphine equivalents (MEQ) [14.1 mg, 106.3 mg] and 50.4 mg MEQ [28.4 mg, 91.2 mg], respectively. The median difference was -9.8 mg MEQ (95% CI -30.7-16.5 mg; P = 0.43). There was no difference in hospital length of stay between both cohorts (P = 0.67). CONCLUSIONS: We found that the addition of a regional anesthesia fellow to the APS team was not associated with statistically significant differences in total opioid consumption or hospital length of stay in this surgical population. The addition of trainees to the infrastructure, with vigilant supervision, is not associated with change in outcomes.

The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.

OBJECTIVES: States in the US are controlling opioid prescribing to combat the opioid epidemic. Prescription Drug Monitoring Programs (PDMPs) were widely adopted, whereas less attention was given to pain clinic laws. This study examined the associations of mandatory use of PDMPs and pain clinic laws with prescription opioid exposures. METHODS: State-level quarterly prescription opioid exposures reported to the National Poison Data System during 2010-2017 were analyzed. The primary outcome was age-adjusted rates of prescription opioid exposures per 1,000,000 population. The primary policy variables included the implementation of mandatory use of PDMPs alone, the implementation of pain clinic laws alone, and the implementation of both mandatory use of PDMPs and pain clinic laws. Linear regressions were used to examine the associations, controlling for other opioid policies, marijuana policies, socioeconomic factors, state fixed effects, time fixed effects, and state-specific time trends. RESULTS: Requiring mandatory use of PDMPs alone was not associated with significant changes in prescription opioid exposures. The implementation of pain clinic laws with or without concurrent mandatory use of PDMPs was associated with 5 fewer prescription opioid exposures per 1,000,000 population or a 9 % reduction compared to the pre-policy period (p < 0.01). Further analysis revealed that the reduction associated with pain clinic laws was pronounced in exposures reported by healthcare facilities. CONCLUSIONS: This multi-state study provided new evidence that the implementation of pain clinic laws was associated with a significant reduction in prescription opioid exposures. Pain clinic laws may deserve further evaluation and consideration.

Chronic noncancer pain is not associated with accelerated brain aging as assessed by structural magnetic resonance imaging in patients treated in specialized outpatient clinics.

Chronic pain is often associated with changes in brain structure and function, and also cognitive deficits. It has been noted that these chronic pain-related alterations may resemble changes found in healthy aging, and thus may represent accelerated or premature aging of the brain. Here, we test the hypothesis that patients with chronic noncancer pain demonstrate accelerated brain aging compared with healthy control subjects. The predicted brain age of 59 patients with chronic pain (mean chronological age ± SD: 53.0 ± 9.0 years; 43 women) and 60 pain-free healthy controls (52.6 ± 9.0 years; 44 women) was determined using the software brainageR. This software segments the individual T1-weighted structural MR images into gray and white matter and compares gray and white matter images with a large (n = 2001) training set of structural images, using machine learning. Finally, brain age delta, which is the predicted brain age minus chronological age, was calculated and compared across groups. This study provided no evidence for the hypothesis that chronic pain is associated with accelerated brain aging (Welch t test, P = 0.74, Cohen's d = 0.061). A Bayesian independent-samples t test indicated moderate evidence in favor of the null hypothesis (BF01 = 4.875, ie, group means were equal). Our results provide indirect support for recent models of pain-related changes of brain structure, brain function, and cognitive functions. These models postulate network-specific maladaptive plasticity, rather than widespread or global neural degeneration.

Favourable prognosis of trigeminal neuralgia when enrolled in a multidisciplinary management program - a two-year prospective real-life study.

BACKGROUND: Prognosis of medically treated trigeminal neuralgia patients is assumed to be poor, but the evidence is lacking. Thus, prospective real-life studies of medical management of trigeminal neuralgia are warranted. METHODS: This was an observational study. Patients were consecutively enrolled in a structured management program at a specialist centre for facial pain. Optimisation of medical treatment, physiotherapy, psychotherapy, and advice from trained nurses, were parts of the program. Medically intractable patients were referred for neurosurgery. Data-collection was prospective using standardised schemes and patient surveys. The aim was to describe the two-year outcome of medical treatment at the specialist centre. The primary outcome was a 50% reduction in the overall burden of pain according to a Numerical Rating Scale (NRS) after two years. RESULTS: A total of 186 primary TN patients were enrolled in the program of which 103 patients remained medically managed and completed the two-year follow-up. Fifty patients were treated surgically within the first two years of follow-up. Half of the medically managed patients (53 (51%)), had more than a 50% reduction in the overall burden of pain over the two-year period. The overall burden of pain on NRS decreased from mean 5.34 to 3.00, p < 0.01. There was no significant association between primary outcome and sex, depression and/or anxiety, concomitant persistent pain, or neurovascular contact with morphological changes of the trigeminal nerve. CONCLUSIONS: Patients with trigeminal neuralgia improve over a two-year period when enrolled in a structured medical management program. Optimisation of drug treatment, continuous advice and education and support by the multidisciplinary team, referral of the medically intractable patients for surgery or the natural history of the disease, can be some of the reasons for the improvement. The favourable prognosis provides hope and optimism for medically managed TN patients. TRIAL REGISTRATION: Current study was observational, and patients were offered standard clinical care and laboratory workups according to current American Academy of Neurology and European Federation of Neurological Societies treatment guidelines. The study has been registered at ClincalTrials.gov. ID: NCT03838393 .

Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence.

In joint initiatives, the European Headache Federation and Lifting The Burden have described a model of structured headache services (with their basis in primary care), defined service quality in this context, and developed practical methods for its evaluation.Here, in a continuation of the service quality evaluation programme, we set out ten suggested role- and performance-defining standards for specialized headache centres operating as an integral component of these services. Verifiable criteria for evaluation accompany each standard. The purposes are five-fold: (i) to inspire and promote, or stimulate the establishment of, specialized headache centres as centres of excellence; (ii) to define the role of such centres within optimally structured and organized national headache services; (iii) to set out criteria by which such centres may be recognized as exemplary in their fulfilment of this role; (iv) to provide the basis for, and to initiate and motivate, collaboration and networking between such centres both nationally and internationally; (v) ultimately to improve the delivery and quality of health care for headache.

Physician and Patient Survey of Taper Schedule and Family Physician Letters Following Discharged from the Acute Pain Service.

PURPOSE: Following discharge, patients requiring high opioid doses may be at risk for both under- and overdosing, posing a major challenge to community physicians. The aim of this study was to examine the effectiveness and degree of satisfaction with a personalized taper schedule and physician letter through interviews of patients and physicians. METHODS: This was a 1-year prospective study. Following ethics approval and informed written consent, patients admitted for elective surgery, 18 to 60 years of age, receiving opioid analgesics, were recruited. Prior to discharge, the acute pain service team provided patients with a taper schedule explained in detail. Individualized physician letters were faxed to treating family physicians. Patients were contacted by phone 2, 4, and 6 weeks after discharge. Physicians were contacted once, a month after discharge. Patients and physicians were asked to grade the taper schedule on a 1- to 5-point Likert scale. Questions pertained to clarity, usefulness, ability to follow the instructions, and general satisfaction. RESULTS: Twenty-six patients and 21 physicians completed the study. Physicians were generally satisfied with both the taper schedule and letter and rated all aspects between 3.76 and 4.38 of 5. Similarly, patients were satisfied with the taper schedule and rated all aspects between 4.08 and 4.5. CONCLUSIONS: Both physicians and patients generally found the taper schedule and letter helpful in assisting them to taper off their opioid use. This is one way of bridging the gap in continuity of care between the acute and primary care providers while reducing the risk to patients during the transition period.

The experience of setting up a resident-managed Acute Pain Service: a descriptive study.

BACKGROUND: The benefits of an Acute Pain Service (APS) for pain management have been widely reported, but its diffusion is still limited. There are two APS models: anesthesiologist-based and a nurse-based model. Here we describe the development of a different APS model managed by anesthesia residents, and we report the first year of activity in a tertiary Italian university hospital (Careggi University Hospital, Florence, IT). METHODS: Patients were included in the APS were those undergoing abdominal and urologic surgery causing moderate or severe postsurgical pain. The service was provided for patients, beginning upon their exit from the operating room, for 4, 12, 24 and 48 h for iv, and up to 72 h for epidural therapy. Vital signs, static/dynamic VAS, presence of nausea/vomiting, sedation level, and Bromage scale in case of epidural catheter, were monitored. RESULTS: From September 2013 to April 2015, a total of 1054 patients who underwent major surgery were included in the APS: 542 from abdominal surgery and 512 from urological surgery. PCA and epidural analgesia were more adopted in general surgical patients than in urology (48% vs 36% and 15% vs 2%, respectively; P < 0.0001). Patients who underwent to abdominal surgery had a significantly higher self-administration of morphine (30.3 vs 22.7 mg; P = 0.0315). Elastomeric pump was the analgesic of choice in half of the urologic patients compared to a quarter of the general surgical patients (P < .0001). Among the different surgical techniques, epidural analgesia was used more in open (16.5%) than in videolaparoscopic (1.9%) and robotic technique (1.1%), whereas PCA was predominant in videolaparoscopic (46.5%) and robotic technique (55.5%) than in open technique (31.4%). CONCLUSIONS: The creation of APS, managed by anesthesia residents, may represent an alternative between specialist-based and nurse-based models.

Inter- and intra-patient variability in breakthrough pain episodes of opioid-treated patients with underlying chronic pain. An observational, prospective and multicenter study / Variabilidad inter- e intra-individual en pacientes con dolor irruptor tratados con opioides. Estudio observacional, prospectivo y multicéntrico

Objective: Since, to date, there are few epidemiological data assessing the diversity in the characteristics of breakthrough pain episodes, the present study was performed to assess the intra-individual variability in the episodes of breakthrough pain in patients with underlying chronic pain controlled with opioids. Methods: An observational, prospective and multicenter study (CADI study) was conducted in the context of the routine clinical practice of Spanish pain specialists recruiting opioidtreated patients with underlying chronic pain. Data were recorded in three visits (baseline, at 7 and 28 days post-inclusion) and by the patient on a patient´s diary card, specifically designed to characterise the first 8 breakthrough pain episodes (type, intensity –using 100 mm Visual Analog Scale– and duration of pain), to assess the intra-individual and inter-individual variability in the intensity, duration and typology of episodes of breakthrough pain. Results: 50 opioid-treated patients were recruited (23 with oncologic pain and 27 with non oncologic pain, mean age of 61.1 years, 62 % females). For all three parameters, inter-patient variability was higher than intra-patient variability throughout the episodes. Nevertheless, we found intra-patient variability in maximum pain intensity, pain intensity at the end of the episode, pain relief and duration of the episode. Conclusions: This is the first study to quantify the intrapatient variability of breakthrough pain. The results show a great variability in terms of intensity and duration of the episode and its typology. Although inter-patient variability is higher, the intra-patient variability is important enough to be taken into account in optimizing the approach and treatment selection (AU)

Objetivos: Debido a los pocos datos epidemiológicos existentes que evalúen la diversidad de las características de los episodios de dolor irruptivo, se realizó el presente estudio, cuyo principal objetivo fue evaluar la variabilidad intraindividual de las crisis de dolor irruptivo en pacientes con dolor crónico controlado con opioides. Métodos: Este estudio observacional, prospectivo y multicéntrico (estudio CADI) se llevó a cabo en el contexto de la práctica clínica habitual, en Unidades del Dolor de España, con la participación de pacientes tratados con opioides para el dolor crónico. Los datos fueron registrados en tres visitas (basal, a los 7 y 28 días después de la inclusión) y por el propio paciente, en un Diario del Paciente, específicamente diseñado para caracterizar los primeros 8 episodios de dolor irruptivo (tipo, intensidad −utilizando la Escala Analógica Visual (EVA)− y duración del dolor) con el objetivo de evaluar la variabilidad intraindividual e interindividual en la intensidad, duración y tipología de los episodios de dolor irruptivo. Resultados: Se reclutaron 50 pacientes, 23 con dolor oncológico y 27 con el dolor no oncológico (edad media de 61,1 años; 62 % de mujeres). Aunque para los tres parámetros medidos, la variabilidad entre pacientes fue mayor que la variabilidad intrapaciente, la variabilidad intraindividual fue significativa en la evaluación de la máxima intensidad del dolor, la intensidad del dolor al final del episodio, el alivio del dolor y la duración del episodio de dolor irruptivo. Conclusiones: Este es el primer estudio que cuantifica la variabilidad intraindividual del dolor irruptivo. Los resultados muestran una gran variabilidad en cuanto a la intensidad y la duración del episodio y su tipología. Aunque la variabilidad entre pacientes es mayor, la variabilidad intrapaciente es lo suficientemente importante como para ser tenida en cuenta para la mejor aproximación y selección del tratamiento (AU)

El alivio del dolor: un derecho humano universal / Pain relief: An universal human right

El dolor es uno de los síntomas que más sufrimiento produce en cualquier enfermedad y constituye un problema básico de salud en todo el mundo. Sin embargo, con frecuencia no recibe el tratamiento adecuado por razones culturales, religiosas, actitudes de la sociedad y de los profesionales sanitarios, así como por motivos políticos y económicos. Desde el punto de vista ético, aliviar el dolor es un derecho del ser humano y una obligación de los profesionales sanitarios. La responsabilidad de los profesionales en lo que respecta a proporcionar un control adecuado del dolor está recogida en el Juramento Hipocrático y en la Declaración de Ginebra, que exige ante todo velar por la salud del paciente. Desde un punto de vista legislativo, la legislación internacional en materia de derechos humanos obliga a los Estadosfirmantes a proteger con todos los recursos a su alcance los derechos que la misma garantiza, sin establecer expresamente el derecho a un alivio adecuado del dolor. Sin embargo, el derecho a la salud lleva implícito el derecho a un adecuado tratamiento del dolor. La Constitución Española de 1978, en su artículo 43, reconoce el derecho a la protección de la salud y por tanto el derecho de los ciudadanos a recibir una asistencia sanitaria adecuada. Así mismo, el artículo 43 incluye que compete a los poderes públicos organizar y tutelar la salud pública a través de medidas preventivas y de las prestaciones y servicios necesarios. Aun no contemplando expresamente el derecho al alivio del dolor, garantiza una adecuada asistencia sanitaria que no puede dejar de lado un tema tan importante como es el tratamiento del dolor. La Organización Mundial de la Salud (OMS) determinó que el alivio del dolor es un derecho fundamental y que incurre en una falta de ética grave aquel profesional de la salud que impida a un ser humano el acceso a la posibilidad de alivio del mismo. La OMS ha dictado los criterios indispensables para un buen control del dolor, entre los que recoge la adecuada formación de los profesionales de la salud y la disponibilidad de fármacos para el tratamiento del dolor. La actitud o comportamiento del que descuida algo o se descuida en algo se denomina 'negligencia'. Se podrían denominar así situaciones en las que no se realiza una terapéutica analgésica adecuada existiendo medios suficientes para hacerlo. Entre las razones que explican esta situación de 'negligencia terapéutica' se encuentra la reticencia a prescribir fármacos opioides debido a un miedo desmesurado a los efectos indeseables de los mismos, la prescripción a dosis inferiores a las analgésicas, a intervalos de dosificación superiores a los recomendados o en pautas a demanda, la administración de menos dosis de los fármacos prescritos por parte de Enfermería en la creencia errónea de que no deben suministrarse los analgésicos pautados cuando el enfermo se encuentra sin dolor y la resignación de los enfermos a sufrir dolor (AU)

Pain is one of the symptoms that more suffering produces in any disease, being a basic health problem worldwide. However, they often do not receive suitable treatment for cultural, religious, societal and health professionals attitudes as well as political and economic reasons. From the ethical point of view relieve pain is a human right and an obligation for health professionals. The responsibility of professionals with regard to providing adequate pain control is contained in the Hippocratic Oath and the Declaration of Geneva that guarantee the patients’ health. From a legislative perspective, international law on human rights forces signatories States to protect with all the resources at its disposal the guaranteed rights without expressly establish the right to adequate pain relief . However, the health right implies the right to an adequate pain management. The article 43 of the Spanish Constitution of 1978 recognizes the right to health protection and therefore the right of citizens to receive adequate health care. Likewise, Article 43 includes a matter for the public authorities to organize and safeguard public health through preventive measures and the necessary benefits and services. Even without specifically contemplating the right to pain relief, an adequate health care cannot ignore an important issue as pain relief. The World Health Organization (WHO), has stated that pain relief is a fundamental right and that incurs in a severe lack of ethic of the health professional who prevents a human from accessing the possibility of pain alleviation. WHO has issued the necessary criteria for a good pain control among which includes appropriate training of health professionals and the availability of drugs for the treatment of pain. The attitude or behavior that neglects something or neglected something is called negligence. They might as well be called situations where there are enough means to perform analgesic therapy and yet it is not done. The reasons for this situation of therapeutic negligence include reluctance to prescribe opioids due to the fear of the undesirable effects of them, prescribing a lower analgesic doses, prescribing drugs at intervals of exceeding the recommended dosage or is demand patterns, delivery by nurses of less doses of the prescribed drug believing that they should not administer the treatment when the patient does not have pain and finally resignation of patients to suffer pain (AU)

An analysis of multidisciplinary staffing levels and clinical activity in Australian tertiary persistent pain services.

OBJECTIVE: To document staffing (medical, nursing, allied health [AH], administrative) in Australian multidisciplinary persistent pain services and relate them to clinical activity levels. METHODS: Of the 68 adult outpatient persistent pain services approached (Dec'08-Jan'10), 45 agreed to participate, received over 100 referrals/year, and met the contemporaneous International Association for the Study of Pain criteria for Level 1 or 2 multidisciplinary services. Structured interviews with Clinical Directors collected quantitative data regarding staff resources (disciplines, amount), services provided, funding models, and activity levels. RESULTS: Compared with Level 2 clinics, Level 1 centers reported higher annual demand (referrals), clinical activity (patient numbers) and absolute numbers of medical, nursing and administrative staff, but comparable numbers of AH staff. When staffing was assessed against activity levels, medical and nursing resources were consistent across services, but Level 1 clinics had relatively fewer AH and administrative staff. Metropolitan and rural services reported comparable activity levels and discipline-specific staff ratios (except occupational therapy). The mean annual AH staffing for pain management group programs was 0.03 full-time equivalent staff per patient. CONCLUSIONS: Reasonable consistency was demonstrated in the range and mix of most disciplines employed, suggesting they represented workable clinical structures. The greater number of medical and nursing staff within Level 1 clinics may indicate a lower multidisciplinary focus, but this needs further exploration. As the first multidisciplinary staffing data for persistent pain clinics, this provides critical information for designing and implementing clinical services. Mapping against clinical outcomes to demonstrate the impact of staffing patterns on safe and efficacious treatment delivery is required.

Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program.

BACKGROUND: In Florida, oxycodone-caused deaths declined substantially in 2012. Multiple important law enforcement, pharmaceutical, policy, and public health actions occurred concurrently, including implementation of a statewide Prescription Drug Monitoring Program (PDMP). The effects of the PDMP on oxycodone-caused mortality in Florida were evaluated. METHODS: A time-series, quasi-experimental research design with autoregressive integrated moving average (ARIMA) statistical models, including internal and external covariates. Data included 120 repeated monthly observations. Monthly counts of oxycodone-caused deaths, obtained from the Florida Medical Examiners Commission (MEC) was the outcome variable. Models included market-entry of tamper-resistant oxycodone HC1 controlled release tablets (OxyContin(®)), enforcement crackdowns (Operation Pill Nation), and regulation by FL House Bill 7095, measured by the monthly count of Florida pain management clinics closed. Two approaches were used to test the PDMP's hypothesized effect: (1) a binary indicator variable (0=pre-implementation, 1=post-implementation), and (2) a continuous indicator consisting of the number of PDMP queries by health care providers. RESULTS: Oxycodone-caused mortality abruptly declined 25% the month after implementation of Florida's PDMP (p=0.008). The effect remained after integrating other related historical events into the model. Results indicate that for a system-wide increase of one PDMP query per health care provider, oxycodone-caused deaths declined by 0.229 persons per month (p=0.002). CONCLUSIONS: This is the first study to demonstrate that the PDMP had a significant effect in reducing oxycodone-caused mortality in Florida. Results have implications for national efforts to address the prescription drug epidemic.

Neuralgia del pudendo: algoritmo de manejo diagnóstico y terapéutico desde una unidad del dolor / Pudendal neuralgia: algorithm for diagnostic and therapeutic management in a pain unit

Objetivo. Presentar un algoritmo de manejo del dolor perineal crónico severo con sospecha de neuralgia del trigémino. Casos. Se presentan 3 casos clínicos con etiología y evolución clínica diversa. Discusión. Análisis de los criterios diagnósticos y tratamientos vigentes. Evaluación de los casos a la luz del algoritmo de diagnóstico y tratamiento propuesto (AU)

Objective. To describe a new algorithm for the management of severe chronic perineal pain/pudendal neuralgia. Cases. We report 3 clinical cases with different etiologies and outcomes. Discussion. We analyze the diagnostic criteria and treatments and evaluate the rational management of these patients according to the algorithm (AU)

Tratamiento sintomático y del dolor en fibromialgia mediante abordaje multidisciplinar desde Atención Primaria / Symptomatic pain and fibromyalgia treatment through multidisciplinary approach for primary care

Introducción. La fibromialgia es una enfermedad crónica de etiología desconocida, caracterizada por dolor muscular generalizado, afectando al desempeño ocupacional, familiar, social, físico y psicológico. El abordaje multidisciplinar de la enfermedad aporta mejoría en la calidad de vida y sintomatología del paciente. Objetivos. Valorar la mejoría de actividades de la vida diaria (AVD) y calidad de vida tras una intervención multidisciplinar (Atención Primaria y Terapia Ocupacional). Material y método. Estudio pretest-postest, con muestreo aleatorio simple, en 21 pacientes con fibromialgia (rango 16-55 años). La medición se realiza con la escala de Barthel (ABVD), la escala de Lawton y Brody (AIVD), cuestionario FIQ y encuestas no estandarizadas para valorar situación pre y postintervención. Se realizó una intervención sobre psicomotricidad (psicomotricidad básica, ejercicio en piscina, ejercicio al aire libre, reestructuración, desempeño ocupacional y actividad graduada e intervención en ABVD), asociando control farmacológico de su sintomatología y tratamiento. Resultados y conclusiones. Los enfermos de fibromialgia no están totalmente conformes con el tratamiento que reciben, Atención Primaria recibe una valoración de 6,89, y la Atención Hospitalaria de 5,79, mejorando los índices de Barthel y de Lawton y Brody, y el cuestionario FIQ, de forma estadísticamente significativa (p < 0,05). Tras la intervención combinada, aumenta el número de mujeres independientes en ABVD y AIVD (AU)

Introduction. Fibromyalgia is a chronic disease of unknown etiology characterized by widespread muscle pain, with occupational, familial, social, physical and psychological performance involvement. The multidisciplinary approach to the disease leads to improvement in quality of life and symptomatology. Objectives. To evaluate the improvement of activities of daily living (ADL) and quality of life following a multidisciplinary intervention (Health Primary Care and Occupational Therapy). Materials and methods. Pretest–posttest study performed with a simple random sample of 21 patients with fibromyalgia (range 16–55 years). The measurement was performed with the Barthel scale (ADL), the scale of Lawton and Brody (IADL), the FIQ questionnaire, and no standardized surveys to assess the pre- and post-intervention situation. An intervention on motor skills (basic motor skills, pool exercise, outdoor exercise, restructuring, occupational performance and graded activity and intervention in ADL) was performed, combining pharmacological control of their symptoms and treatment. Results and conclusions. Fibromyalgia patients are not fully satisfied with their treatment; Primary Care receives a score of 6.89, and Hospital Care 5.79, improving the Barthel, Lawton and Brody and FIQ indexes, being statistically significant (P<.05). After the combined procedure the number of independent women in ADL and IADL increases (AU)